Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Generation of Atrioventricular Node pacemaker cells from human pluripotent stem cells

EF 2018-19

Résumé
In Canada alone, 21,000 electronic pacemaker (EPM) devices are implanted each year, saving the lives of patients with Sinoatrial Node (SAN) and Atrioventricular Node (AVN) associated diseases or defects. The SAN initiates electrical signals that drive the heartbeat, whereas the AVN is responsible for propagating these electric signals from the upper heart chambers to the bottom heart chambers, ultimately activating their contraction and resulting in the pumping of blood through the body. Failure of either pacemaker tissue leads to a life-threatening irregular or slow heartbeat that needs to be treated with an EPM. However, such devices are not without disadvantages, lacking autonomic responsiveness and putting patients at risk for infection when surgery is required to replace the battery every 5-10 years. Pediatric patients must also undergo additional refitting surgeries due to a lack of growth adaptation. The ability to functionally replace dead or damaged tissue with a biological pacemaker (BioPM) is a promising solution to these caveats. Recently, our lab has been successful in generating SAN pacemaker cells from stem cells and have shown that these cells are able to function as a BioPM in rat hearts. Currently, no protocols exist to derive AVN pacemaker cells from stem cells. In this study, we aim to identify methods to derive these AVN cells and functionally characterize their pacemaker phenotype. The use of AVN pacemaker cells as a BioPM in adult and pediatric AVN-block patients is a potential cure that will replace the need for an EPM in Canada and worldwide.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
422400
Name
Lohbihler Michelle E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Generation of Atrioventricular Node pacemaker cells from human pluripotent stem cells
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Atrioventricular Node; Atrioventricular Node-Block; Biological Pacemaker; Cardiomyocytes; Cardiovascular; Conduction Bridge; Congenital Heart Disease; Developmental Signaling Pathways; Pluripotent Stem Cells; Stem Cell Differentiation
Abstract
In Canada alone, 21,000 electronic pacemaker (EPM) devices are implanted each year, saving the lives of patients with Sinoatrial Node (SAN) and Atrioventricular Node (AVN) associated diseases or defects. The SAN initiates electrical signals that drive the heartbeat, whereas the AVN is responsible for propagating these electric signals from the upper heart chambers to the bottom heart chambers, ultimately activating their contraction and resulting in the pumping of blood through the body. Failure of either pacemaker tissue leads to a life-threatening irregular or slow heartbeat that needs to be treated with an EPM. However, such devices are not without disadvantages, lacking autonomic responsiveness and putting patients at risk for infection when surgery is required to replace the battery every 5-10 years. Pediatric patients must also undergo additional refitting surgeries due to a lack of growth adaptation. The ability to functionally replace dead or damaged tissue with a biological pacemaker (BioPM) is a promising solution to these caveats. Recently, our lab has been successful in generating SAN pacemaker cells from stem cells and have shown that these cells are able to function as a BioPM in rat hearts. Currently, no protocols exist to derive AVN pacemaker cells from stem cells. In this study, we aim to identify methods to derive these AVN cells and functionally characterize their pacemaker phenotype. The use of AVN pacemaker cells as a BioPM in adult and pediatric AVN-block patients is a potential cure that will replace the need for an EPM in Canada and worldwide.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lohbihler, Michelle E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~